Dr. Jeffrey M. Kenkel Offers Ultherapy: A Breakthrough Cosmetic Treatment for Dallas-Area Patients

Share Article

Dr. Jeffrey M. Kenkel now offers Ultherapy to Dallas patients. A first of its kind treatment for improvement of sagging skin.

This represents a whole new category within aesthetic medicine. My patients are thrilled to have an effective ‘entry level’ option for improving sagging skin that doesn’t entail cutting or downtime.

Jeffrey Kenkel, MD, Dallas cosmetic surgeon and president of the American Society for Aesthetic Plastic Surgery (ASAPS), announced today that Ultherapy, a significant advancement in nonsurgical skin tightening performed to lift and tone the skin, is available at his office. Ultherapy (a registered trademark of Ulthera, Inc.) has captured the interest of the medical community and top news media across the country. Dr. Kenkel has 18 months of experience with the device.

“This represents a whole new category within aesthetic medicine,” says Dr. Kenkel. “My patients are thrilled to have an effective ‘entry level’ option for improving sagging skin that doesn’t entail cutting or downtime.” Kenkel adds “patient selection is critical to successful outcomes with any procedure.”

The use of FDA-cleared ultrasound technology enables physicians, for the first time, to see and then treat the deepest support layers of the skin addressed in surgery without disrupting the uppermost layers of skin. There can be some initial contraction, but the ultrasound energy also triggers the body’s natural response mechanism, which rejuvenates tired collagen and supplements it with fresh, new collagen. This will strengthen and tone the skin over a few months and gently shift it into a more youthful position. While the results do not duplicate the results of a surgical procedure such a facelift, Ultherapy’s gradual improvements make it a compelling option for those who are not quite ready for surgery.

Tens of thousands of Ultherapy treatments have been provided worldwide, and Dr. Kenkel is pleased to be at the forefront in the U.S. of this clinical advance, which was cleared by the FDA in September 2009. Dr. Kenkel was involved in Ulthera’s largest clinical study to date to try to gain an additional indication granted by the FDA for a “non-invasive lift of jowl & neck tissue.” The specific-indication currently is for “non-invasive brow lift.”

For more information, contact Dr. Jeffrey M. Kenkel.

Jeffrey M. Kenkel, M.D., F.A.C.S., is a plastic surgeon located in Dallas, Texas. He is a professor and vice chairman of the Department of Plastic Surgery at the University of Texas Southwestern Medical Center at Dallas. He is the director of the Clinical Center for Cosmetic Laser Treatment and medical director for the Department of Plastic Surgery, Outpatient Building, UT Southwestern Medical University at Dallas. His clinical practice is located at the Outpatient Building on the campus of UT Southwestern Medical Center.
Dr. Kenkel is President of American Society for Aesthetic Plastic Surgery (ASAPS), the leading professional organization of plastic surgeons certified by the American Board of Plastic Surgery who specialize in cosmetic plastic surgery. Dr. Kenkel is certified by the ABPS (American Board of Plastic Surgery) and specializes in cosmetic plastic surgery.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jeffrey M. Kenkel, M.D.

Email >
Visit website